Skip to main content
. 2010 May 28;10:140. doi: 10.1186/1471-2334-10-140

Table 1.

Characteristics of study subjects

Characteristics All HIV positive patients HIV negative patients Household contacts Neighborhood controls
Number of study subjects 484 205 179 51 49
Female (%) 220 (45.5) 99 (48.3) 64 (36.0) 33 (64.7) 24 (49.0)
Age median (range) 33 (15-89) 34 (19-70) 32 (15-89) 32 (18-86) 33 (16-55)
 Males 36 (15-89) 37 (23-70) 35 (15-89) 36 (18-60) 32 (16-55)
 Females 32 (16-86) 32 (19-60) 30 (18-77) 30 (18-86) 33 (16-55)
HIV positive (%) 213 (44.0) 205 (100) 0 6 (11.8) 2 (4.1)
TB positive (%) 250 (65.1) 118 (57.6) 132 (73.7) - -
CD4* median (range) 340 (21-2117) 208 (21-926) 387 (49-1609) 622 (146-1714) 465 (180-2117)
CD4* < 200 (%) 112 (23.1) 94 (45.9) 15 (8.4) 1 (2.0) 2 (4.1)
Receiving presumptive antibiotic treatment (%) 175 (46.5) 98 (49.0) 77 (43.8) - -
Receiving presumptive curative TMX**(%) 45 (12.3) 35 (17.8) 10 (5.9) - -
Receiving prophylactic TMX**1 (%) 57 (57.6) 57 (57.6) - - -

All: Information on sex was missing for 1 patient, age was missing for 1 patient, information on presumptive antibiotic treatment was missing for 8 patients, information on presumptive curative TMX missing for 10 patients.

HIV positive: information on presumptive antibiotic treatment was missing for 5 patients. Information on presumptive curative TMX was missing for 3 patients.

HIV negative: age missing for 1 patient, sex missing for 1 patient. Information regarding presumptive antibiotic treatment was missing for 3 patients, information on presumptive curative TMX missing for 7 patients.

*CD4, number of CD4 cells per mm3. **TMX: cotrimoxazole

1 Number of patients receiving prophylactic TMX out of all patients known HIV positive before study entry.